71th-Cardio-Website_EN-Mob

Satellite Sessions

June 3 , 2024

AstraZeneca | 07:00-08:00

Title: TTRansforming Care in Amyloidosis

 Click here to view agenda.

  • Hall G

Novo Nordisk | 12:30-14:00

Title: Navigating Residual Risk in T2D- Innovative Strategies for Improved Outcomes

Click here to view agenda.

  • Hall M

Bayer + AstraZeneca | 12:30-14:00

Title: Heart and Kidney in Harmony: The Game-Changing Potential of SGLT2i & ns-MRA

Click here to view agenda.

  • Hall E

Medison Pharma | 12:30-14:00

Title: Optical Illusion of the PCSK9 Treatment: You Can Get Much More Than What You See

Click here to view agenda.

  • Hall GF

Pfizer Pharmaceuticals Israel | 12:30-14:00

Title: Can We Do BeTTR? Optimizing diagnosis of Cardiac Amyloidosis in Herat Failure Patients

Click here to view agenda

  • Hall I

Abbott Laboratories | 12:30-14:00

Title: Mitral & TriCuspid interventions – where experience matters

Click here to view Agenda

  • Hall KL

June 4 , 2024

Novo Nordisk | 12:30-14:00

Title: Mending broken hearts with GLP-1 in obesity management

Click here to view agenda.

  • Hall E

Boehringer Ingelheim Israel | 12:30-14:00

Title: International Latest Updates in Treatment for Heart Failure

Click here to view agenda.

  • Hall GF

Pfizer | 12:30-14:00

Title: Navigating Cardiac Amyloidosis: Echocardiography and Differential Diagnosis in Focus

Session is open for medical technicians

Click here to view agenda.

Hall H

Novartis Israel | 12:30-14:00

Title: Heart Frontiers: Today’s Lipid Innovations, Tomorrow’s Standards

Click here to view agenda.

  • Hall I

Edwards Lifesciences | 12:30-14:00

Title: RESILIA Innovation Session

Click here to view agenda

  • Hall KL

Medtechnica | 12:30-14:00

Title: Expanding Horizons to Improve Outcome- Intra Coronary Imaging

Click here to view agenda

  • Hall M